![Ashley Webb](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Johnny Page | M | - |
Bolden Therapeutics, Inc.
![]() Bolden Therapeutics, Inc. BiotechnologyHealth Technology Bolden Therapeutics, Inc. is a biotechnology company that is developing first-in-class therapeutics to treat central nervous system diseases. The company's research facilities are based within Tufts Launchpad Biolabs, a leading incubator for next-generation powerhouse biotech startups located in Providence, RI. The company's scientific co-founders, Dr. Justin Fallon and Dr. Ashley E. Webb, have identified a key molecular pathway to stimulate neural stem cells to promote the birth of new neurons in the adult brain. Bolden is developing antisense oligonucleotides to modulate this genetically-validated target. The company was founded by Justin Fallon, Ashley E. Webb, and Johnny Page. Johnny Page has been the CEO since incorporation. | - |
Charles Polsky | M | - |
Bolden Therapeutics, Inc.
![]() Bolden Therapeutics, Inc. BiotechnologyHealth Technology Bolden Therapeutics, Inc. is a biotechnology company that is developing first-in-class therapeutics to treat central nervous system diseases. The company's research facilities are based within Tufts Launchpad Biolabs, a leading incubator for next-generation powerhouse biotech startups located in Providence, RI. The company's scientific co-founders, Dr. Justin Fallon and Dr. Ashley E. Webb, have identified a key molecular pathway to stimulate neural stem cells to promote the birth of new neurons in the adult brain. Bolden is developing antisense oligonucleotides to modulate this genetically-validated target. The company was founded by Justin Fallon, Ashley E. Webb, and Johnny Page. Johnny Page has been the CEO since incorporation. | - |
Justin Fallon | M | - |
Bolden Therapeutics, Inc.
![]() Bolden Therapeutics, Inc. BiotechnologyHealth Technology Bolden Therapeutics, Inc. is a biotechnology company that is developing first-in-class therapeutics to treat central nervous system diseases. The company's research facilities are based within Tufts Launchpad Biolabs, a leading incubator for next-generation powerhouse biotech startups located in Providence, RI. The company's scientific co-founders, Dr. Justin Fallon and Dr. Ashley E. Webb, have identified a key molecular pathway to stimulate neural stem cells to promote the birth of new neurons in the adult brain. Bolden is developing antisense oligonucleotides to modulate this genetically-validated target. The company was founded by Justin Fallon, Ashley E. Webb, and Johnny Page. Johnny Page has been the CEO since incorporation. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 3 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Ashley Webb
- Réseau Personnel